Vernakalant Versus Ibutilide In Recent-Onset Atrial Fibrillation
Condition(s):Atrial FibrillationLast Updated:May 13, 2015Completed
Hide Studies Not Open or Pending
Condition(s):Atrial FibrillationLast Updated:May 13, 2015Completed
Condition(s):Persistent Atrial FibrillationLast Updated:February 14, 2018Completed
Condition(s):Atrial Fibrillation; Pulmonary Vein AblationLast Updated:January 31, 2012Unknown status
Condition(s):Atrial Fibrillation; Persistent Atrial FibrillationLast Updated:February 10, 2020Terminated
Condition(s):Long QT Syndrome; Abnormalities, Drug-InducedLast Updated:February 6, 2024Recruiting
Condition(s):Long QT Syndrome; Abnormalities, Drug-InducedLast Updated:August 1, 2023Recruiting
Condition(s):Prolonged QT Interval in EKG and Sudden DeathLast Updated:October 30, 2015Completed
Condition(s):Long QT SyndromeLast Updated:August 28, 2019Completed
Condition(s):Atrial FibrillationLast Updated:April 12, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.